Trackinsight Enterprise, a unified platform for institutional ETF research, analytics, and compliance, is now live. Explore Trackinsight Enterprise →
Help us improve your experience. Please confirm your investor type:
The Ultimate ETF Comparison Tool - Try Now!
Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.
ETFs with exposure to Jazz Pharmaceuticals Plc (JAZZ)
Global X Marijuana Life Sciences Index ETF - CAD This ETF provides exposure to North American Equities | 12.35% | -2.45% | -5.11% | -€340K | -€768K | €27M | 1% | |
|---|---|---|---|---|---|---|---|---|
4.79% | +6.18% | +8.39% | +€67M | -€6M | €318M | 0.51% | Not rated | |
3.84% | +9.19% | +16.62% | +€134M | +€128M | €997M | 0.38% | ||
Invesco Dynamic Pharmaceuticals ETF - USD This ETF provides exposure to Equally Weighted US Pharmaceuticals Equities | 3.78% | +9.54% | +13.11% | -€9.9M | -€204K | €311M | 0.57% | |
3.47% | +9.77% | +8.65% | €0 | -€584K | €18M | 0.49% | ||
First Trust Nasdaq Pharmaceuticals ETF - USD This ETF provides exposure to Other US Pharmaceuticals Equities | 2.66% | +11.40% | +16.63% | -€1.5M | +€8.9M | €32M | 0.6% | |
2.56% | +2.38% | +1.37% | -€1.5M | +€7.4M | €20M | 0.7% | Not rated | |
State Street SPDR S&P Pharmaceuticals ETF - USD This ETF provides exposure to Equally Weighted US Pharmaceuticals Equities | 2.31% | +13.95% | +16.85% | +€24M | +€119M | €371M | 0.35% | |
Invesco DWA Healthcare Momentum ETF - USD This ETF provides exposure to Other US Health Care Equities | 2.23% | +18.18% | +20.89% | +€344K | -€8.6M | €122M | 0.72% | |
2.17% | -0.13% | +7.85% | -€869 | +€9.1M | €49M | 0.49% | Not rated | |
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
Privacy policy | Cookie policy | | Terms of use | Imprint
